Damnacanthal-induced anti-inflammation is associated with inhibition of NF-kB activity

Inflammation and Allergy - Drug Targets

Volumn 10, Issue 6, 2011, Pages 455-463

  Nualsanit, Thararat ^a,b   Rojanapanthu, Pleumchitt ^b   Gritsanapan, Wandee ^b   Kwankitpraniti, Thiwanporn ^c   Min, Kyung Won ^a   Baek, Seung Joon ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

COX 2; Damnacanthal; INOS; Morinda citrifolia L. (Rubiaceae); NF kB

Indexed keywords

ACTIN; CD68 ANTIGEN; CYCLOOXYGENASE 2; DAMNACANTHAL; DEXAMETHASONE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EAR EDEMA; EDEMA; ENZYME REPRESSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MEDICINAL PLANT; MORINDA CITRIFOLIA; MOUSE; NONHUMAN; PAW EDEMA; PROTEIN EXPRESSION; RAT; TRADITIONAL MEDICINE;

EID: 81155126242     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152811798104908     Document Type: Article

References (39)

1. Wang, M. Y.; West, B. J.; Jensen, C. J.; Nowicki, D.; Su, C.; Palu, A. K.; Anderson, G. Morinda citrifolia (Noni):A literature review and recent advances in Noni research. Acta Pharmacol. Sin., 2002, 23 (12), 1127-1141.
2. Lemmens, R.; Bunyapraphatsara, N. Plant resources of South-East Asia. Backhuys Publishers: Leiden, Netherlands, 2003; Vol. 12, pp. 302-305.
3. Pawlus, A. D.; Kinghorn, A. D. Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). J. Pharm. Pharmacol., 2007, 59, 1587-1609.
4. Chan-Blanco, Y.; Vaillant, F.; Perez, A.M.; Reynes, M.; Brillouet, J-M.; Brat, P. The noni fruit (Morinda citrifolia L.): A review of agricultural research, nutritional and therapeutic properties. J. Food Compost. Anal., 2006, 19, 645-654.
5. Rastogi, R. P.; Mehrotra, B. N. Compendium of Indian medicinal plants. Central Drug Research Institute: New Delhi, 1960-1969; Vol. 1.
6. Mahattanadul, S.; Ridtitid, W.; Nima, S.; Phdoongsombut, N.; Ratanasuwon, P.; Kasiwong, S. Effects of Morinda citrifolia aqueous fruit extract and its biomarker scopoletin on reflux esophagitis and gastric ulcer in rats. J. Ethnopharmacol., 2011, 134 (2), 243-250.
7. Dussossoy, E.; Brat, P.; Bony, E.; Boudard, F.; Poucheret, P.; Mertz, C.; Giaimis, J.; Michel, A. Characterization, anti-oxidative and anti-inflammatory effects of Costa Rican noni juice (Morinda citrifolia L.). J. Ethnopharmacol., 2011, 133 (1), 108-115.
8. Akihisa, T.; Matsumoto, K.; Tokuda, H.; Yasukawa, K.; Seino, K.; Nakamoto, K.; Kuninaga, H.; Suzuki, T.; Kimura, Y. Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni). J. Nat. Prod., 2007, 70 (5), 754-757.
9. West, B. J.; Deng, S.; Palu, A. K.; Jensen, C. J. Morinda citrifolia Linn. (Rubiaceae) leaf extracts mitigate UVB-induced erythema. J. Nat. Med., 2009, 63 (3), 351-354.
10. Faltynek, C.R.; Schroeder, J.; Mauvais, P.; Miller, D.; Wang, S.; Murphy, D.; Lehr, R.; Kelley, M.; Maycock, A.; Michne, W. Damnacanthal is a highly potent, selective inhibitor of p56lck tyrosine kinase activity. Biochemistry, 1995, 34, 12404-12410.
11. Kanokmedhakul, K.; Kanokmedhakul, S.; Phatchana, R. Biological activity of anthraquinones and triterpenoids from Prismatomeris fragrans. J. Ethnopharmacol., 2005, 100, 284-288.
12. Kang, J. L.; Jung, H. J.; Lee, K.; Kim, H. R. Src tyrosine kinases mediate crystalline silica-induced NF-kappaB activation through tyrosine phosphorylation of IkappaB-alpha and p65 NF-kappaB in RAW 264.7 macrophages. Toxicol. Sci., 2006, 90 (2), 470-477.
13. Jobin, C.; Sartor, R. B. The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. Am. J. Physiol. Cell Physiol., 2000, 278 (3), C451-462.
14. Libby, P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr., 2006, 83 (2), 456S-460S.
15. Packard, R. R.; Libby, P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem., 2008, 54 (1), 24-38.
16. Aggarwal, B. B. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu. Rev. Nutr., 2010, 30, 173-199.
17. Jackson, L.; Evers, B. M. Chronic inflammation and pathogenesis of GI and pancreatic cancers. Cancer Treat. Res., 2006, 130, 39-65.
18. Schottenfeld, D.; Beebe-Dimmer, J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J. Clin., 2006, 56 (2), 69-83.
19. Ee, G. C.; Wen, Y. P.; Sukari, M. A.; Go, R.; Lee, H. L. A new anthraquinone from Morinda citrifolia roots. Nat. Prod. Res., 2009, 23 (14), 1322-1329.
20. Kamiya, K.; Hamabe, W.; Tokuyama, S.; Hirano, K.; Satake, T.; Kumamoto-Yonezawa, Y.; Yoshida, H.; Mizushina, Y. Inhibitory effect of anthraquinones isolated from the Noni (Morinda citrifolia) root on animal A-, B- and Y-families of DNA polymerases and human cancer cell proliferation. Food. Chemistry, 2010, 118 (3), 725-730.
21. Koumaglo, K.; Gbeassor, M.; Nikabu, O.; Souza, C.D.; Werner, W. Effects of three compounds extracted from Morinda lucida on Plasmodium falciparum. Planta Med., 1992, 58, 533-534.
22. Niemegeers, C. J.; Verbruggen, F. J.; Janssen, P. A. Effect of Various Drugs on Carrageenin-Induced Oedema in the Rat Hind Paw. J. Pharm. Pharmacol., 1964, 16, 810-816.
23. Williamson, E.; Okpako, D.; Evans, F., Anti-inflammatory and analgesic activity. In Pharmacological methods in phytotherapy research Volume I, John Willey&Sons Ltd: England, 1996; Vol. 1, pp 131-154.
24. Dunstan, C. A.; Noreen, Y.; Serrano, G.; Cox, P. A.; Perera, P.; Bohlin, L. Evaluation of some Samoan and Peruvian medicinal plants by prostaglandin biosynthesis and rat ear oedema assays. J. Ethnopharmacol., 1997, 57 (1), 35-56.
25. Akihisa, T.; Yasukawa, K.; Oinuma, H.; Kasahara, Y.; Yamanouchi, S.; Takido, M.; Kumaki, K.; Tamura, T. Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects. Phytochemistry, 1996, 43 (6), 1255-1260.
26. Sosa, S.; Balick, M. J.; Arvigo, R.; Esposito, R. G.; Pizza, C.; Altinier, G.; Tubaro, A. Screening of the topical anti-inflammatory activity of some Central American plants. J. Ethnopharmacol., 2002, 81 (2), 211-215.
27. Koki, A. T.; Masferrer, J. L. Celecoxib: a specific COX-2 inhibitor with anticancer properties. Cancer Control, 2002, 9 (2 Suppl), 28-35.
28. Inoue, H.; Umesono, K.; Nishimori, T.; Hirata, Y.; Tanabe, T. Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochem. Biophys. Res. Commun., 1999, 254 (2), 292-298.
29. McKoy, M. L.; Thomas, E. A.; Simon, O. R. Preliminary investigation of the anti-inflammatory properties of an aqueous extract from Morinda citrifolia (noni). Proc. West Pharmacol. Soc., 2002, 45, 76-78.
30. Luqman, S.; Pezzuto, J. M. NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother. Res., 2010, 24 (7), 949-963.
31. Hsieh, C. H.; Jeng, S. F.; Hsieh, M. W.; Chen, Y. C; Rau, C. S.; Lu, T. H.; Chen, S.S. Statin-induced heme oxygenase-1 increases NF-kappaB activation and oxygen radical production in cultured neuronal cells exposed to lipopolysaccharide. Toxicol. Sci., 2008, 102 (1), 150-159.
32. Okusada, K.; Nakamoto, K.; Nishida, M.; Fujita-Hamabe, W.; Kamiya, K.; Mizushina, Y.; Satake, T.; Tokuyama, S. The Antinociceptive and Anti-inflammatory Action of the CHCl(3)-Soluble Phase and Its Main Active Component, Damnacanthal, Isolated from the Root of Morinda citrifolia. Biol. Pharm. Bull, 2011, 34 (1), 103-107.
33. Karin, M.; Delhase, M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol, 2000, 12 (1), 85-98.
34. Chen, C. X.-J.; Soto, I.; Guo, Y.-L.; Liu, Y. Control of Secondary Granule Release in Neutrophils by Ral GTPase. J. Biol. Chem., 2011, 286 (13), 11724-11733.
35. Phillippe, M.; Sweet, L. M.; Bradley, D. F.; Engle, D. Role of Nonreceptor Protein Tyrosine Kinases During Phospholipase C-y1-related Uterine Contractions in the Rat. Reprod. Sci., 2009, 16 (3), 265-273.
36. Hiramatsu, T.; Imoto, M.; Koyano, T.; Umezawa, K. Induction of normal phenotypes in ras-transformed cells by damnacanthal from Morinda citrifolia. Cancer Letters, 1993, 73 (2-3), 161-166.
37. Abraham, N. G.; Kappas, A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev., 2008, 60 (1), 79-127.
38. Wagener, F. A.; Volk, H. D.; Willis, D.; Abraham, N. G.; Soares, M. P.; Adema, G. J.; Figdor, C. G. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev., 2003, 55 (3), 551-571.
39. Kobayashi, H.; Takeno, M.; Saito, T.; Takeda, Y.; Kirino, Y.; Noyori, K.; Hayashi, T.; Ueda, A.; Ishigatsubo, Y. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum., 2006, 54 (4), 1132-1142.